The single most upsetting fact to note is that prior to dosing our troops, there were no studies done on drug interactions. But, there were clinically noted contraindications for mefloquine long before the drug was released to the general public in 1989. By the early 1990’s, it was clear that adverse reactions were so common and significant in concurrent dosing of mefloquine and opiates, anti-anxieties, anti-depressants, anti-psychotics and sleep-aids, warnings were attached to the label. Each of those drugs cause symptoms that are identical to PTSD. Mefloquine causes symptoms that are identical to PTSD. Now, we are sending our troops into combat with compromised nervous systems from mefloquine toxicity, exposing them to the stressors assumed to be the prime cause of PTSD, then treating those symptoms with more drugs that also cause symptoms of PTSD. And the Deparment of Defense and the Army in particular are surprised and baffled at the skyrocketing rates of PTSD and suicide among our military and veterans.